Retour sur lavenir.net
   TUBIZE-FIN 217.600 € (-0,27 %)     EKOPAK 4.000 € (+1,78 %)     AB INBEV 70.480 € (+0,09 %)     UCB 247.500 € (-0,68 %)     ARGENX SE 769.400 € (+0,87 %)     ELIA GROUP 131.300 € (-0,30 %)     COLRUYT 34.100 € (-0,06 %)     NYRSTAR 0.065 € (0,00 %)     AGEAS 67.550 € (+0,52 %)     KBC 119.550 € (+0,42 %)     BPOST 1.610 € (-0,37 %)     SOLVAY 27.400 € (-1,44 %)     SOFINA 222.000 € (+0,27 %)     KBC ANCORA 82.000 € (+0,24 %)     WDP 21.680 € (-0,28 %)     D'IETEREN GROUP 161.600 € (-2,06 %)     GBL 79.300 € (0,00 %)     BANQUP GROUP 2.620 € (+11,02 %)     AZELIS GROUP 9.875 € (+0,77 %)     SYENSQO 67.350 € (-0,37 %)     UMICORE 22.900 € (-3,46 %)     PROXIMUS 6.140 € (-0,41 %)     RECTICEL 10.980 € (+1,10 %)     BARCO 8.590 € (-1,15 %)     DECEUNINCK 2.305 € (+1,32 %)     MELEXIS 81.550 € (-1,75 %)     IBA 16.590 € (+3,04 %)     MONTEA 65.700 € (-0,30 %)     NYXOAH 1.418 € (+1,29 %)     EVS 29.550 € (-0,17 %)     AEDIFICA 68.000 € (+0,07 %)     VGP 82.000 € (-0,49 %)     RETAIL ESTATES 68.600 € (-0,44 %)     VIOHALCO 20.700 € (+4,86 %)     COFINIMMO 80.000 € (+0,44 %)     CMB.TECH 12.600 € (+1,45 %)     ACKERMANS V.HAAREN 286.600 € (-0,42 %)     SHURGARD 23.950 € (-0,83 %)     FLUXYS BELGIUM D 19.650 € (0,00 %)     CENERGY 25.260 € (+1,12 %)     TITAN S.A. 53.350 € (-1,75 %)     HOME INVEST BE. 19.400 € (0,00 %)     TESSENDERLO 20.700 € (+0,49 %)     CFE 12.800 € (+1,59 %)     KINEPOLIS GROUP 35.250 € (-0,56 %)     CAMPINE 223.000 € (+0,45 %)     BREDERODE 102.200 € (-0,20 %)     SIPEF 92.600 € (+0,11 %)     CELYAD ONCOLOGY 0.250 € (-6,37 %)     OPTION 5.960 € (-5,10 %)     BIOTALYS 3.200 € (+0,16 %)     ONWARD MEDICAL 2.640 € (-0,75 %)     IMMOBEL 23.100 € (-3,75 %)     TINC 11.640 € (0,00 %)     BEKAERT 41.800 € (-0,71 %)     ASCENCIO 52.000 € (+0,58 %)     WERELDHAVE BELGIUM 52.600 € (+0,77 %)     XIOR 26.050 € (+0,19 %)     JENSEN-GROUP 84.400 € (+1,69 %)     DEME GROUP 181.400 € (-0,22 %)  
   EXOSENS 60.750 € (+2,02 %)     FDJ UNITED 22.370 € (-0,71 %)     CVC CAPITAL 12.930 € (-0,84 %)     VIRIDIEN 92.050 € (+2,11 %)     AYVENS 11.770 € (-1,09 %)     OPMOBILITY 14.120 € (-0,77 %)     LIGHTON 6.150 € (+3,36 %)     CSG 14.332 € (+0,48 %)     PROSUS 38.730 € (-0,92 %)     SANOFI 74.850 € (+2,06 %)     DSM FIRMENICH AG 77.100 € (+0,50 %)     PLANISWARE 18.020 € (+0,11 %)     AXA 42.550 € (+0,35 %)     DANONE 65.280 € (-0,64 %)     VIEL ET COMPAGNIE 17.720 € (-0,45 %)     DASSAULT AVIATION 301.600 € (+0,13 %)     WOLTERS KLUWER 58.600 € (+0,69 %)     SENSORION 0.264 € (+14,07 %)     ASML HOLDING 1 668.400 € (-0,45 %)     SCOR SE 31.280 € (+0,45 %)     ALSTOM 16.130 € (-0,43 %)     ADYEN 889.500 € (-1,58 %)     BAM GROEP KON 12.490 € (0,00 %)     ASM INTERNATIONAL 1 056.500 € (-1,31 %)     ARCELORMITTAL SA 55.320 € (-0,97 %)     SOCIETE GENERALE 78.150 € (+0,13 %)     BE SEMICONDUCTOR 310.100 € (-2,42 %)     AVANTIUM 7.980 € (-0,25 %)     CAPGEMINI 89.220 € (+0,25 %)     BOLLORE 5.545 € (+2,69 %)     PHILIPS KON 23.340 € (-0,68 %)     OVH 16.530 € (-5,22 %)     EURONEXT 146.200 € (-0,07 %)     HEINEKEN HOLDING 63.350 € (-0,78 %)     VALEO 13.535 € (+0,93 %)     AHOLD DEL 34.725 € (+0,59 %)     VINCI 129.750 € (-0,69 %)     EDP RENEWABLES 13.510 € (-0,07 %)     STELLANTIS NV 5.615 € (+0,81 %)     UNILEVER 50.480 € (-0,75 %)     FORVIA 9.450 € (+0,45 %)     PERNOD RICARD 63.460 € (-0,63 %)     HERMES INTL 1 729.000 € (-1,93 %)     COVIVIO 53.600 € (-0,19 %)     BNP PARIBAS ACT.A 101.240 € (+0,14 %)     THERACLION 0.682 € (-9,07 %)     SAINT GOBAIN 78.920 € (-1,05 %)     AIR LIQUIDE 166.500 € (-0,37 %)     LVMH 506.300 € (+0,24 %)     ASR NEDERLAND 66.080 € (+0,73 %)     SARTORIUS STED BIO 163.200 € (-1,39 %)     DASSAULT SYSTEMES 17.125 € (+0,26 %)     EUTELSAT COMMUNIC. 2.371 € (-0,17 %)     L'OREAL 376.950 € (-2,72 %)     KERING 271.600 € (-1,79 %)     KLEPIERRE 35.420 € (-1,28 %)     TKH GROUP 44.420 € (-0,63 %)     X-FAB 9.070 € (-8,48 %)     MICHELIN 33.470 € (+0,21 %)     KPN KON 4.335 € (+0,32 %)  
News Réglementées
16/06/2026 07:00

AEVIS VICTORIA SA: A further step in its transformation into an investment company with Infracore’s Intention to Float

AEVIS VICTORIA SA / Key word(s): IPO
AEVIS VICTORIA SA: A further step in its transformation into an investment company with Infracore’s Intention to Float

16-Jun-2026 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 16 June 2026

AEVIS VICTORIA SA: A further step in its transformation into an investment company with Infracore’s Intention to Float

AEVIS VICTORIA SA («AEVIS») notes the announcement by Infracore SA («Infracore») of its Intention to Float, as a first step towards a potential initial public offering.

This milestone represents an important step in Infracore’s development and is fully aligned with AEVIS’ strategy to continue its transformation into an investment company built around strategic, transparent and value-creating assets.

Infracore is a strategic participation of AEVIS within its healthcare investment portfolio. The company owns and develops a unique portfolio of healthcare real estate assets in Switzerland, benefiting from high-quality properties, strong visibility and a differentiated positioning in a sector supported by long-term structural demand.

Infracore’s Intention to Float is expected to enhance the visibility of this participation, improve transparency regarding its market value and contribute to a clearer recognition of AEVIS’ intrinsic value as an investment company.

AEVIS considers Infracore a long-term strategic investment. In this context, AEVIS intends to retain its entire stake in Infracore alongside its partner Medical Properties Trust, Inc. («MPT»), in order to support the company in its next phase of development.

This development represents a further step towards greater clarity regarding the value of AEVIS’ key participations. It also illustrates the Group’s ambition to bring to the market independent, solid and well-positioned platforms within its portfolio.

AEVIS will continue to pursue its long-term value creation strategy, focusing its resources on strategic participations in healthcare, hospitality and related infrastructure sectors.

For further information
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Marion Schihin, msc@dynamicsgroup.ch, +41 79 705 88 15
Séverine Van der Schueren, svanderschueren@aevis.com, +41 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.



End of Inside Information

2346564  16-Jun-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière